1. Home
  2. MGNI vs KYMR Comparison

MGNI vs KYMR Comparison

Compare MGNI & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGNI
  • KYMR
  • Stock Information
  • Founded
  • MGNI 2007
  • KYMR 2015
  • Country
  • MGNI United States
  • KYMR United States
  • Employees
  • MGNI N/A
  • KYMR N/A
  • Industry
  • MGNI Computer Software: Programming Data Processing
  • KYMR Medicinal Chemicals and Botanical Products
  • Sector
  • MGNI Technology
  • KYMR Health Care
  • Exchange
  • MGNI Nasdaq
  • KYMR Nasdaq
  • Market Cap
  • MGNI 3.1B
  • KYMR 3.1B
  • IPO Year
  • MGNI N/A
  • KYMR 2020
  • Fundamental
  • Price
  • MGNI $24.16
  • KYMR $44.10
  • Analyst Decision
  • MGNI Strong Buy
  • KYMR Strong Buy
  • Analyst Count
  • MGNI 12
  • KYMR 16
  • Target Price
  • MGNI $25.75
  • KYMR $58.94
  • AVG Volume (30 Days)
  • MGNI 2.8M
  • KYMR 657.9K
  • Earning Date
  • MGNI 08-06-2025
  • KYMR 08-11-2025
  • Dividend Yield
  • MGNI N/A
  • KYMR N/A
  • EPS Growth
  • MGNI N/A
  • KYMR N/A
  • EPS
  • MGNI 0.29
  • KYMR N/A
  • Revenue
  • MGNI $685,074,000.00
  • KYMR $44,711,000.00
  • Revenue This Year
  • MGNI $0.43
  • KYMR $58.45
  • Revenue Next Year
  • MGNI $11.49
  • KYMR N/A
  • P/E Ratio
  • MGNI $84.75
  • KYMR N/A
  • Revenue Growth
  • MGNI 5.52
  • KYMR N/A
  • 52 Week Low
  • MGNI $8.22
  • KYMR $19.45
  • 52 Week High
  • MGNI $25.27
  • KYMR $53.27
  • Technical
  • Relative Strength Index (RSI)
  • MGNI 58.63
  • KYMR 55.66
  • Support Level
  • MGNI $21.03
  • KYMR $41.50
  • Resistance Level
  • MGNI $24.54
  • KYMR $44.06
  • Average True Range (ATR)
  • MGNI 1.30
  • KYMR 1.82
  • MACD
  • MGNI -0.01
  • KYMR 0.28
  • Stochastic Oscillator
  • MGNI 90.05
  • KYMR 94.90

About MGNI Magnite Inc.

Magnite Inc is one of the supply-side platform providers, or SSP, in online advertising. The firm generate its revenue from the programmatic sale of CTV ad inventory, from mobile online sites and apps, and the remaining from websites accessed via computer.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: